InvestorsHub Logo
Followers 2
Posts 253
Boards Moderated 0
Alias Born 07/26/2017

Re: Radar02 post# 15734

Friday, 01/19/2018 5:06:11 PM

Friday, January 19, 2018 5:06:11 PM

Post# of 17821
I'm down about 50% from my average here atm. Unless I actually see more of the same dilution behavior from the past in the next 10-Q, I'm holding this through the summer. The renegotiation of debt last month tells me that they are actually trying to mitigate the effect of the notes. The FDA approval for Epidiolex (https://www.gwpharm.com/epilepsy-patients-caregivers/patients) this summer will likely send this company through the roof as long as they keep building out the business at this pace. The practitioner side of the business will go gangbusters as long as they prepare before the summer. I saw the numerous posts they had posted for sales positions across the nation when the company first announced the acquisition. The next 10-Q should reflect all of these things, but we'll have to wait and see. I've been on this board since last Sep, so I'll try to put together a DD post this weekend with all of the details going back to then. It's a LOT.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent HYEX News